Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis

참고문헌 (140)

1. Peterson, C. L., "Histones and histone modifications", Curr. Biol, 14, pp.R546~R551 (2004)
2. Bannister, A. J., "Regulation of chromatin by histone modifications", Cell Res, 21, pp.381~395 (2011)
3. Rea, S., "Regulation of chromatin structure by site-specific histone H3methyltransferases", Nature, 406, pp.593~599 (2000)
4. Paik, W. K., "Enzymatic demethylation of calf thymus histones", Biochem. Biophys. Res. Commun, 51, pp.781~788 (1973)
5. Peters, A. H., "Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability", Cell, 107, pp.323~337 (2001)
6. Pasini, D., "Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity", EMBO J, 23, pp.4061~4071 (2004)
7. Blair, L. P., "Epigenetic regulation by lysine demethylase 5(KDM5)enzymes in cancer", Cancers(Basel), 3, pp.1383~1404 (2011)
8. Jangravi, Z., "Two splice variants of Y chromosome-located lysine-specific demethylase 5D have distinct function in prostate cancer cell line(DU-145)", J. Proteome Res, 14, pp.3492~3502 (2015)
9. Jensen, L. R., "Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation", Am. J. Hum. Genet, 76, pp.227~236 (2005)
10. Yang, G. J., "The emerging role of KDM5A in human cancer", J. Hematol. Oncol, 14, pp.30~ (2021)
11. Peng, D., "Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor", Cell Death Discov, 7, pp.9~ (2021)
12. Klein, B. J., "The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers", Cell Rep, 6, pp.325~335 (2014)
13. Brier, A. B., "The KDM5 family is required for activation of pro-proliferative cell cycle genes during adipocyte differentiation", Nucleic Acids Res, 45, pp.1743~1759 (2017)
14. Liu, X., "The histone demethylase KDM5 activates gene expression by recognizing chromatin context through Its PHD reader motif", Cell Rep, 13, pp.2219~2231 (2015)
15. Lange, C., "Cdks and cyclins link G1 length and differentiation of embryonic, neural and hematopoietic stem cells", Cell Cycle, 9, pp.1893~1900 (2010)
16. Calder, A., "Lengthened G1 phase indicates differentiation status in human embryonic stem cells", Stem Cells Dev, 22, pp.279~295 (2013)
17. Coronado, D., "A short G1 phase is an intrinsic determinant of naive embryonic stem cell pluripotency", Stem Cell Res, 10, pp.118~131 (2013)
18. Beshiri, M. L., "Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation", Proc. Natl Acad. Sci. USA, 109, pp.18499~18504 (2012)
19. Lopez-Bigas, N., "Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation", Mol. Cell, 31, pp.520~530 (2008)
20. Christensen, J., "RBP2 belongs to a family of demethylases, specific for triand dimethylated lysine 4 on histone 3", Cell, 128, pp.1063~1076 (2007)
21. Pasini, D., "Coordinated regulation of transcriptional repression by the RBP2H3K4 demethylase and polycomb-repressive complex 2", Genes Dev, 22, pp.1345~1355 (2008)
22. Ohguchi, Y., "Diverse functions of KDM5 in cancer: transcriptional repressor or activator?", Cancers (Basel), 14, pp.3270~ (2022)
23. Dey, B. K., "The histone demethylase KDM5b", JARID1b plays a role in cell fate decisions by blocking terminal differentiation, 2008, pp.28, 5312~5327
24. Yamane, K., "PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation", Mol. Cell, 25, pp.801~812 (2007)
25. Benevolenskaya, E. V., "Binding of pRB to the PHD protein RBP2 promotes cellular differentiation", Mol. Cell, 18, pp.623~635 (2005)
26. Kong, S. Y., "The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells", FASEB J, 32, pp.1108~1119 (2018)
27. Nishio, H., "Distinctive changes in histone H3K4 modification mediated via Kdm5a expression in spermatogonial stem cells of cryptorchid testes", J. Urol, 191, pp.1564~1572 (2014)
28. Madsen, B., "PLU-1, a transcriptional repressor and putative testis-cancer antigen, has a specific expression and localisation pattern during meiosis", Chromosoma, 112, pp.124~132 (2003)
29. Cui, Y., "Pig KDM5B : mRNA expression profiles of different tissues and testicular cells and association analyses with testicular morphology traits", Gene, 650, pp.27~33 (2018)
30. Chen, J., "Two faces of bivalent domain regulate VEGFA responsiveness and angiogenesis", Cell Death Dis, 11, pp.75~ (2020)
31. Fork, C., "Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5", Arterioscler. Thromb. Vasc. Biol, 35, pp.1645~1652 (2015)
32. Varaljai, R., "Increased mitochondrial function downstream from KDM5A histone demethylase rescues differentiation in pRB-deficient cells", Genes Dev, 29, pp.1817~1834 (2015)
33. Rojas, A., "Epigenetic control of the bone-master Runx2 gene during osteoblastlineage commitment by the histone demethylase JARID1B", KDM5B, 2015, pp.290, 28329~28342
34. Guo, L., "Histone demethylase KDM5A is transactivated by the transcription factor C", EBPbeta and promotes preadipocyte differentiation by inhibiting Wnt, J. Biol. Chem, pp.2019, 294[DOI]
35. Gage, F. H., "Mammalian neural stem cells", Science, 287, pp.1433~1438 (2000)
36. Schmitz, S. U., "Jarid1b targets genes regulating development and is involved in neural differentiation", EMBO J, 30, pp.4586~4600 (2011)
37. Kubota, H., "Spermatogonial stem cells", Biol. Reprod, 99, pp.52~74 (2018)
38. Simpson, A. J., "Cancer", testis antigens, gametogenesis and cancer, 2005, pp.5, 615~625
39. Nagamori, I., "Relationship between PIWIL4-Mediated H3K4me2 Demethylation and piRNA-dependent DNA methylation", Cell Rep, 25, pp.350~356 (2018)
40. Kobayashi, H., "High-resolution DNA methylome analysis of primordial germ cells identifies gender-specific reprogramming in mice", Genome Res, 23, pp.616~627 (2013)
41. Aravin, A. A., "Developmentally regulated piRNA clusters implicate MILI in transposon control", Science, 316, pp.744~747 (2007)
42. Zacksenhaus, E., "pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis", Genes Dev, 10, pp.3051~3064 (1996)
43. de Bruin, A., "Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice", Proc. Natl Acad. Sci. USA, 100, pp.6546~6551 (2003)
44. Novitch, B. G., "Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle", J. Cell Biol, 135, pp.441~456 (1996)
45. Faundes, V., "Histone lysine methylases and demethylases in the landscape of human developmental disorders", Am. J. Hum. Genet, 102, pp.175~187 (2018)
46. Kidder, B. L., "KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation", Genome Biol, 15, pp.R32~ (2014)
47. Najmabadi, H., "Deep sequencing reveals 50 novel genes for recessive cognitive disorders", Nature, 478, pp.57~63 (2011)
48. Vallianatos, C. N., "Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders", Epigenomics, 7, pp.503~519 (2015)
49. Lebrun, N., "Novel KDM5B splice variants identified in patients with developmental disorders : Functional consequences", Gene, 679, pp.305~313 (2018)
50. Silva, I. M., "A 1.5Mb terminal deletion of 12p associated with autism spectrum disorder", Gene, 542, pp.83~86 (2014)
51. Han, J. Y., "Variable phenotypes of epilepsy, intellectual disability, and schizophrenia caused by 12p13.33-p13.32 terminal microdeletion in a Korean family: a case report and literature review", Genes (Basel), 12, pp.1001~ (2021)
52. Iossifov, I., "The contribution of de novo coding mutations to autism spectrum disorder", Nature, 515, pp.216~221 (2014)
53. Athanasakis, E., "Next generation sequencing in nonsyndromic intellectual disability: from a negative molecular karyotype to a possible causative mutation detection", Am. J. Med. Genet. A, 164A, pp.170~176 (2014)
54. De Rubeis, S., "Synaptic, transcriptional and chromatin genes disrupted in autism", Nature, 515, pp.209~215 (2014)
55. Miolo, G., "A novel mosaic 1q32.1 microduplication identified through chromosome microarray analysis: narrowing the smallest critical region including KDM5B gene found associated with neurodevelopmetal disorders", Eur. J. Med. Genet, 62, pp.103558~ (2019)
56. Martin, H. C., "Quantifying the contribution of recessive coding variation to developmental disorders", Science, 362, pp.1161~1164 (2018)
57. Szot, J. O., "A Screening approach to identify clinically actionable variants causing congenital heart disease in exome data", Circ. Genom. Precis. Med, 11, pp.e001978~ (2018)
58. Zhou, W., "Notch1-mediated histone demethylation of HCN4 contributes to aconitine-induced ventricular myocardial dysrhythmia", Toxicol. Lett, 327, pp.19~31 (2020)
59. Ji, W., "De novo damaging variants associated with congenital heart diseases contribute to the connectome", Sci. Rep, 10, pp.7046~ (2020)
60. Li, Y., "Histone demethylase JARID1B regulates proliferation and migration of pulmonary arterial smooth muscle cells in mice with chronic hypoxia-induced pulmonary hypertension via nuclear factor-kappa B(NFkB)", Cardiovasc. Pathol, 37, pp.8~14 (2018)
61. van der Linde, D., "Birth prevalence of congenital heart disease worldwide : a systematic review and meta-analysis", J. Am. Coll. Cardiol, 58, pp.2241~2247 (2011)
62. Laraja, K., "Neurodevelopmental outcome in children after fetal cardiac intervention for aortic stenosis with evolving hypoplastic left heart syndrome", J. Pediatr, 184, pp.130~136.e4 (2017)
63. Jin, S. C., "Contribution of rare inherited and de novo variants in 2, 871congenital heart disease probands", Nat. Genet, 49, pp.1593~1601 (2017)
64. Wang, C., "KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis", Cell Death Dis, 7, pp.e2335~ (2016)
65. Zhang, X., "Extracellular vesicle-encapsulated miR-29b-3p released from bone marrow-derived mesenchymal stem cells underpins osteogenic differentiation", Front. Cell Dev. Biol, 8, pp.581545~ (2020)
66. Zhao, M., "Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata", Br. J. Dermatol, 166, pp.226~273 (2012)
67. Ma, Y. S., "KDM5A silencing transcriptionally suppresses the FXYD3-PI3K", AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation, 2021, pp.25, 4040~4052
68. Li, Q., "Binding of the JmjC demethylase JARID1B to LSD1", NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14, 2011, pp.71, 6899~6908
69. Zhang, Z. G., "KDM5B promotes breast cancer cell proliferation and migration via AMPK-mediated lipid metabolism reprogramming", Exp. Cell Res, 379, pp.182~190 (2019)
70. Catchpole, S., "PLU-1", JARID1B, Int. J. Oncol, pp.2011, 38[DOI]
71. Mocavini, I., "JARID1B expression and its function in DNA damage repair are tightly regulated by miRNAs in breast cancer", Cancer Sci, 110, pp.1232~1243 (2019)
72. Madsen, B., "Characterisation and developmental expression of mouse Plu-1, a homologue of a human nuclear protein(PLU-1)which is specifically upregulated in breast cancer", Gene Expr. Patterns, 2, pp.275~282 (2002)
73. Barrett, A., "Breast cancer associated transcriptional repressor PLU-1", JARID1B interacts directly with histone deacetylases, 2007, pp.121, 265~275
74. Lu, P. J., "A novel gene(PLU-1)containing highly conserved putative DNA", chromatin binding motifs is specifically up-regulated in breast cancer, 1999, pp.274, 15633~15645
75. Barrett, A., "PLU-1 nuclear protein, which is upregulated in breast cancer, shows restricted expression in normal human adult tissues : a new cancer", testis antigen? Int, 2002, pp.101, 581~588
76. Hou, J., "Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer", Am. J. Transl. Res, 4, pp.247~256 (2012)
77. Cao, J., "Histone demethylase RBP2 is critical for breast cancer progression and metastasis", Cell Rep, 6, pp.868~877 (2014)
78. Yamamoto, S., "JARID1B is a luminal lineage-driving oncogene in breast cancer", Cancer Cell, 25, pp.762~777 (2014)
79. Mitra, D., "Jumonji", ARID1 B(JARID1B)protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e, 2011, pp.286, 40531~40535
80. Spangle, J. M., "PI3K", AKT signaling regulates H3K4 methylation in breast cancer, 2016, pp.15, 2692~2704
81. Foulkes, W. D., "Triple-negative breast cancer", N. Engl. J. Med, 363, pp.1938~1948 (2010)
82. Bamodu, O. A., "Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448", BMC Cancer, 16, pp.160~ (2016)
83. Paolicchi, E., "Histone lysine demethylases in breast cancer", Crit. Rev. Oncol. Hematol, 86, pp.97~103 (2013)
84. Secombe, J., "The function and regulation of the JARID1 family of histone H3 lysine 4 demethylases : the Myc connection", Cell Cycle, 6, pp.1324~1328 (2007)
85. Liefke, R., "Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex", Genes Dev, 24, pp.590~601 (2010)
86. Yeh, I. J., "Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer", Sci. Rep, 9, pp.17663~ (2019)
87. Cariou, S., "Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1", Breast Cancer Res. Treat, 52, pp.29~41 (1998)
88. Vieira, F. Q., "Deregulated expression of selected histone methylases and demethylases in prostate carcinoma", Endocr. Relat. Cancer, 21, pp.51~61 (2014)
89. Xiang, Y., "JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer", Proc. Natl Acad. Sci. USA, 104, pp.19226~19231 (2007)
90. Yang, Z., "Analysis of key genes reveal lysine demethylase 5B promotes prostate cancer progression", Oncol. Lett, 20, pp.62~ (2020)
91. Li, G., "KDM5B is essential for the hyperactivation of PI3K", AKT signaling in prostate tumorigenesis, 2020, pp.80, 4633~4643
92. Khan, M. I., "AKT inhibition modulates H3K4 demethylase levels in PTEN-null prostate cancer", Mol. Cancer Ther, 18, pp.356~363 (2019)
93. Du, C., "Activation of the KDM5A", miRNA-495, m6A-MOB3B axis facilitates prostate cancer progression, pp.J. Exp. Clin. Cancer Res, 2020[DOI]
94. Johansson, C., "Structural analysis of human KDM5B guides histone demethylase inhibitor development", Nat. Chem. Biol, 12, pp.539~545 (2016)
95. Tumber, A., "Potent and selective KDM5 inhibitor stops cellular demethylation of H3K4me3 at transcription start sites and proliferation of MM1S myeloma cells", Cell Chem. Biol, 24, pp.371~380 (2017)
96. Vinogradova, M., "An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells", Nat. Chem. Biol, 12, pp.531~538 (2016)
97. Paroni, G., "HER2-positive breast-cancer cell lines are sensitive to KDM5inhibition : definition of a gene-expression model for the selection of sensitive cases", Oncogene, 38, pp.2675~2689 (2019)
98. Gilmore, S., "Antiviral activity of GS-5801, a liver-targeted prodrug of a lysine demethylase 5 inhibitor, in a hepatitis B virus primary human hepatocyte infection model", J. Hepatol, 1, pp.S690~S691 (2017)
99. Yang, G. J., "Selective inhibition of lysine-specific demethylase 5A(KDM5A)using a rhodium(III)complex for triple-negative breast cancer therapy", Angew. Chem. Int. Ed. Engl, 57, pp.13091~13095 (2018)
100. Yang, G. J., "Structure-based discovery of a selective KDM5A inhibitor that exhibits anti-cancer activity via inducing cell cycle arrest and senescence in breast cancer cell lines", Cancers(Basel), 11, pp.92~ (2019)
101. Hee-Joo Choi, "Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer", JNCI: Journal of the National Cancer Institute, 110(4), pp.400~410 (2017), Oxford University Press (OUP)[DOI]
102. Coleman, J. A., "T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients", Int. J. Cancer, 128, pp.2114~2124 (2011)
103. Zhao, L. H., "Immunohistochemical detection and clinicopathological significance of JARID1B", KDM5B and P16 expression in invasive ductal carcinoma of the breast, 2015, pp.14, 5417~5426
104. Hayami, S., "Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis : involvement in the proliferation of cancer cells through the E2F", RB pathway, 2010, pp.9, 59~
105. Ohta, K., "Depletion of JARID1B induces cellular senescence in human colorectal cancer", Int. J. Oncol, 42, pp.1212~1218 (2013)
106. McCann, T. S., "KDM5A and PHF2 positively control expression of prometastatic genes repressed by EWS", Fli1, and promote growth and metastatic properties in Ewing sarcoma, 2020, pp.11, 3818~3831
107. Zeng, J., "The histone demethylase RBP2 Is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells", Gastroenterology, 138, pp.981~992 (2010)
108. Li, Y., "NEK2 promotes proliferation, migration and tumor growth of gastric cancer cells via regulating KDM5B", H3K4me3, 2019, pp.9, 2364~2378
109. Banelli, B., "The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma", Cell Cycle, 14, pp.3418~3429 (2015)
110. Romani, M., "Targeting of histone demethylases KDM5A and KDM6B inhibits the proliferation of temozolomideresistant glioblastoma cells", Cancers(Basel), 11, pp.878~ (2019)
111. Dai, B., "Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1", Biomed. Pharmacother, 99, pp.72~80 (2018)
112. Dai, B., "Overexpressed KDM5B is associated with the progression of glioma and promotes glioma cell growth via downregulating p21", Biochem. Biophys. Res. Commun, 454, pp.221~227 (2014)
113. Fang, L., "Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma", Int. J. Mol. Med, 38, pp.172~182 (2016)
114. You, J. H., "Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelialmesenchymal transition", Cancer Lett, 507, pp.40~54 (2021)
115. Li, H., "Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors : a rational approach to preclinical model selection", Mol. Cancer Res, 12, pp.571~582 (2014)
116. Huang, D., "KDM5B overexpression predicts a poor prognosis in patients with squamous cell carcinoma of the head and neck", J. Cancer, 9, pp.198~204 (2018)
117. Cui, Z., "PLU-1", JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma, 2015, pp.33, 2454~2460
118. Wang, D., "Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27", J. Exp. Clin. Cancer Res, 35, pp.37~ (2016)
119. Oser, M. G., "The KDM5A", RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis, 2019, pp.33, 1718~1738
120. Teng, Y. C., "Histone demethylase RBP2 promotes lung tumorigenesis and cancer metastasis", Cancer Res, 73, pp.4711~4721 (2013)
121. Kuo, K. T., "Histone demethylase JARID1B", KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor, 2018, pp.10, 107~
122. Roesch, A., "Retinoblastoma-binding protein 2-homolog 1 : a retinoblastoma-binding protein downregulated in malignant melanomas", Mod. Pathol, 18, pp.1249~1257 (2005)
123. Kuzbicki, L., "JARID1B expression in human melanoma and benign melanocytic skin lesions", Melanoma Res, 23, pp.8~12 (2013)
124. Roesch, A., "RBP2-H1", JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells, 2008, pp.122, 1047~1057
125. Ohguchi, H., "Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma", Blood Cancer Discov, 2, pp.370~387 (2021)
126. Wang, W., "Histone demethylase JARID1B is overexpressed in osteosarcoma and upregulates cyclin D1 expression via demethylation of H3K27me3", Oncol. Res, 26, pp.373~384 (2018)
127. Feng, T., "KDM5A promotes proliferation and EMT in ovarian cancer and closely correlates with PTX resistance", Mol. Med. Rep, 16, pp.3573~3580 (2017)
128. Wang, L., "Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer", Tumour Biol, 36, pp.2465~2472 (2015)
129. Lin, W., "Dynamic epigenetic regulation by menin during pancreatic islet tumor formation", Mol. Cancer Res, 13, pp.689~698 (2015)
130. Shen, X., "Jumonji AT-rich interactive domain 1B promotes the growth of pancreatic tumors via the phosphatase and tensin homolog", protein kinase B signaling pathway, 2018, pp.16, 267~275
131. Kumar, A., "Reduction in H3K4me patterns due to aberrant expression of methyltransferases and demethylases in renal cell carcinoma : prognostic and therapeutic implications", Sci. Rep, 9, pp.8189~ (2019)
132. Chan, S. W., "Retinoblastoma-binding protein 2(Rbp2)potentiates nuclear hormone receptor-mediated transcription", J. Biol. Chem, 276, pp.28402~28012 (2001)
133. Zhao, D., "H3K4me3 demethylase Kdm5a is required for NK cell activation by associating with p50 to suppress SOCS1", Cell Rep, 15, pp.288~299 (2016)
134. Peng, J. C., "Jarid2", Jumonji coordinates control of PRC2 enzymatic activity and target gene occupancy in pluripotent cells, 2009, pp.139, 1290~1302
135. Nishibuchi, G., "Physical and functional interactions between the histone H3K4 demethylase KDM5A and the nucleosome remodeling and deacetylase(NuRD)complex", J. Biol. Chem, 289, pp.28956~28970 (2014)
136. Kim, Y. W., "Differential specificity for binding of retinoblastoma binding protein 2 to RB, p107, and TATA-binding protein", Mol. Cell Biol, 14, pp.7256~7264 (1994)
137. Mao, S., "T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2", Oncogene, 14, pp.1531~1539 (1997)
138. Wu Zhou, "The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor", BMB reports, 42(3), pp.154~159 (2009), 한국생화학분자생물학회
139. Roesch, A., "Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cells", J. Invest. Dermatol, 126, pp.1850~1859 (2006)
140. Tan, K., "Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9", J. Biol. Chem, 278, pp.20507~20513 (2003)

관련 논문AI추천